Uncategorized
Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at a public offering price of $7.89 per share, before underwriting discounts and commissions. The offering will result in aggregate gross proceeds of approximately $126.2 m